Marshall Wace, LLP Repare Therapeutics Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 46,876 shares of RPTX stock, worth $55,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,876
Previous 119,108
60.64%
Holding current value
$55,313
Previous $409,000
85.09%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RPTX
# of Institutions
59Shares Held
33.6MCall Options Held
51KPut Options Held
0-
Bvf Inc San Francisco, CA10.3MShares$12.2 Million0.51% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.06 Million1.93% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$3.92 Million0.12% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$3.5 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.12 Million5.13% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $49.5M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...